Viemed Healthcare, Inc. (VMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
VMD POWR Grades
- Quality is the dimension where VMD ranks best; there it ranks ahead of 96.05% of US stocks.
- The strongest trend for VMD is in Momentum, which has been heading down over the past 178 days.
- VMD's current lowest rank is in the Momentum metric (where it is better than 5.76% of US stocks).
VMD Stock Summary
- VMD's current price/earnings ratio is 60.36, which is higher than 91.4% of US stocks with positive earnings.
- The ratio of debt to operating expenses for VIEMED HEALTHCARE INC is higher than it is for about only 5.1% of US stocks.
- With a year-over-year growth in debt of -89.35%, VIEMED HEALTHCARE INC's debt growth rate surpasses just 1.54% of about US stocks.
- Stocks that are quantitatively similar to VMD, based on their financial statements, market capitalization, and price volatility, are TRT, OTLY, TCMD, DCGO, and PESI.
- VMD's SEC filings can be seen here. And to visit VIEMED HEALTHCARE INC's official web site, go to www.viemed.com.
VMD Valuation Summary
- In comparison to the median Healthcare stock, VMD's price/sales ratio is 42.55% lower, now standing at 2.7.
- Over the past 44 months, VMD's price/earnings ratio has gone up 34.4.
Below are key valuation metrics over time for VMD.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| VMD | 2023-03-17 | 2.7 | 3.9 | 60.4 | 39.1 |
| VMD | 2023-03-16 | 2.7 | 3.8 | 59.8 | 38.7 |
| VMD | 2023-03-15 | 2.5 | 3.6 | 56.5 | 36.5 |
| VMD | 2023-03-14 | 2.6 | 3.7 | 57.3 | 37.0 |
| VMD | 2023-03-13 | 2.5 | 3.6 | 56.6 | 36.5 |
| VMD | 2023-03-10 | 2.5 | 3.6 | 56.4 | 36.5 |
VMD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- VMD has a Quality Grade of B, ranking ahead of 93.39% of graded US stocks.
- VMD's asset turnover comes in at 1.029 -- ranking 20th of 81 Healthcare stocks.
- 500 - Internal server error
The table below shows VMD's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 1.029 | 0.627 | 0.182 |
| 2021-06-30 | 1.069 | 0.614 | 0.202 |
| 2021-03-31 | 1.204 | 0.606 | 0.353 |
| 2020-12-31 | 1.234 | 0.610 | 0.396 |
| 2020-09-30 | 1.151 | 0.593 | 0.354 |
| 2020-06-30 | 1.150 | 0.628 | 0.338 |
VMD Price Target
For more insight on analysts targets of VMD, see our VMD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $11.33 | Average Broker Recommendation | 1.5 (Moderate Buy) |
VMD Stock Price Chart Interactive Chart >
VMD Price/Volume Stats
| Current price | $9.99 | 52-week high | $10.00 |
| Prev. close | $9.84 | 52-week low | $4.80 |
| Day low | $9.69 | Volume | 135,800 |
| Day high | $10.00 | Avg. volume | 108,234 |
| 50-day MA | $8.60 | Dividend yield | N/A |
| 200-day MA | $7.01 | Market Cap | 379.82M |
Viemed Healthcare, Inc. (VMD) Company Bio
Viemed Healthcare, Inc. provides health care services. The Company offers respiratory disease management, neuromuscular care, home sleep testing, equipment solutions, sleep apnea treatment, and oxygen therapy services. Viemed Healthcare also offers rental of ventilator and peripheral equipment. Viemed Healthcare serves patients in the United States.
Latest VMD News From Around the Web
Below are the latest news stories about VIEMED HEALTHCARE INC that investors may wish to consider to help them evaluate VMD as an investment opportunity.
Viemed Healthcare Announces 2022 Financial ResultsLAFAYETTE, La., March 02, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, today reported its financial results for the three months and year ended December 31, 2022. Operational highlights (all dollar amounts are USD): Net revenues attributable to the Company's core business for the quarter ended December 31, 2022 were $37.5 million, a new Compa |
Viemed Healthcare: Steady As She Goes |
Viemed Healthcare Announces Date and Time for Conference CallLAFAYETTE, La., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Year End Conference Call on Friday, March 3, 2023 at 11:00 a.m. ET. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free)+1-201-689-8451 (International) Financial professionals are invited to call in to r |
7 A-Rated Healthcare Stocks to Buy for the Future of MedicineSnapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. |
Viemed Wins Complete Overruling of Appealed OIG Claims Resolving Multiyear Process With HHS and CMSLAFAYETTE, La., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced the ruling of a U.S. Department of Health and Human Services Administrative Law Judge (“ALJ”) with respect to the appeal of claims related to findings from the U.S. Department of Health and Human Services Office of Inspector General (“OIG”). The ALJ’s Decision over |
VMD Price Returns
| 1-mo | 9.78% |
| 3-mo | 32.14% |
| 6-mo | 77.44% |
| 1-year | 99.80% |
| 3-year | 113.92% |
| 5-year | 307.34% |
| YTD | 32.14% |
| 2022 | 44.83% |
| 2021 | -32.73% |
| 2020 | 25.16% |
| 2019 | 63.16% |
| 2018 | N/A |
Loading social stream, please wait...